N | % | ||
---|---|---|---|
Sex | Male | 89 | 74 |
Female | 32 | 26 | |
Tumour location | Lung | 34 | 28 |
Rectum | 19 | 16 | |
Skin | 14 | 12 | |
Other | 54 | 45 | |
Metastasis | Yes | 41 | 34 |
No | 80 | 66 | |
Palliative | Yes | 46 | 38 |
No | 75 | 62 | |
Concomitant chemotherapy | Yes | 46 | 38 |
No | 75 | 62 | |
Ambulance | Yes | 70 | 58 |
No | 51 | 42 | |
Inpatient | Yes | 33 | 27 |
No | 88 | 73 | |
Type of early withdrawal | Incomplete course | 58 | 48 |
Any fraction | 63 | 52 | |
Reason for withdrawal | Death due to tumour progression | 35 | 29 |
Clinical progression | 23 | 19 | |
Death due to non-oncology reasons | 17 | 14 | |
Toxicity | 12 | 10 | |
Patient refusal | 10 | 8 | |
Dosimetric issues | 5 | 4 | |
Other | 19 | 16 |